Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.
Sign Up to like & getrecommendations! Published in 2019 at "JAMA ophthalmology"
DOI: 10.1001/jamaophthalmol.2019.5132
Abstract: Importance Radiation retinopathy following plaque radiotherapy for uveal melanoma can lead to vision loss that might be avoided with prophylactic anti-vascular endothelial growth factor treatment. Objective To determine visual outcome following prophylactic intravitreal bevacizumab in… read more here.
Keywords: prophylactic intravitreal; bevacizumab; uveal melanoma; intravitreal bevacizumab ... See more keywords
Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age.
Sign Up to like & getrecommendations! Published in 2020 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.1097/apo.0000000000000271
Abstract: PURPOSE The aim of this study was to determine the impact of age on radiation complications after plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma. DESIGN Retrospective cohort study. METHODS Retrospective single-center study of… read more here.
Keywords: uveal melanoma; intravitreal bevacizumab; radiation; prophylactic intravitreal ... See more keywords